Mankind Pharma - News
NSE: MANKIND | BSE: 543904
₹2,535.00
As on 01-Oct-2026IST
Market cap
₹1,04,376 Cr
Revenue (TTM)
₹14,738 Cr
P/E Ratio
51.1
P/B Ratio
6.2
Div. Yield
0 %
Quarterly Updates
Annual Reports
Announcements
View AnnouncementsIntimation Regarding ESG Rating
15-Sep-2026Update On Voluntary Liquidation Of WOS
07-Sep-2026No News & Announcements are available.